Back to Search Start Over

Pulmonary vascular disease and exercise hemodynamics in chronic liver disease

Authors :
Philipp Douschan
Gabor Kovacs
Teresa Sassmann
Vanessa Stadlbauer
Alexander Avian
Vasile Foris
Elisabeth Tatscher
Franziska Durchschein
Florian Rainer
Walter Spindelboeck
Martin Wagner
Daniela Kniepeiss
Gernot Zollner
Gerhard Bachmaier
Peter Fickert
Horst Olschewski
Rudolf E. Stauber
Source :
Respiratory medicine. 202
Publication Year :
2022

Abstract

Portopulmonary hypertension (POPH) and hepatopulmonary syndrome (HPS) are severe pulmonary vascular complications of chronic liver disease and strongly associated with morbidity and mortality. The prevalence of these complications is relatively high in patients evaluated for liver transplantation, however it is virtually unknown in patients with stable chronic liver disease.We assessed the pulmonary hypertension (PH) and HPS prevalence in a prospective registry study of our liver out-patient clinic in a tertiary center. Between 2011 and 2016, consecutive patients with cirrhosis or non-cirrhotic portal hypertension were prospectively enrolled after written informed consent. We excluded patients with acute decompensation of liver disease and other causes of PH like severe chronic heart or lung diseases and chronic thromboembolic PH. HPS was diagnosed using contrast enhanced echocardiography and blood gas analysis. Patients were screened for PH using an algorithm implementing severity of dyspnea, echocardiography, cardiopulmonary exercise testing and exercise echocardiography employing a threshold of systolic pulmonary arterial pressure (SPAP) = 50 mmHg at peak exercise. If the algorithm indicated an increased PH risk, patients were invited for invasive investigations by means of right heart and hepatic vein catheter. We defined POPH as resting mPAPā‰„21 mmHg and PVR3WU and PAWP15 mmHg, mild PH as resting mPAP = 21-24 mmHg, and exercise PH as mPAP30 mmHg and TPR3 WU at peak exercise.Two-hundred-five patients were enrolled (male 75%; cirrhosis 96%; median age 57 yrs). Sixty-seven patients (33%) fulfilled HPS criteria but only two (1.0%) for severe (PaO2:50-60 mmHg) or very severe HPS (PaO250 mmHg). In 18/77 patients (23%) undergoing exercise echocardiography, SPAP at peak exercise exceeded 50 mmHg. Finally, n = 3 (1.5%) patients were invasively diagnosed with POPH, n = 4 (2.9%) with mild PH and n = 2 with exercise PH.In chronic liver disease, excluding acute decompensation and other causes of PH, POPH and severe HPS are rare findings while mild to moderate HPS and mild PH or exercise PH are more frequent.

Details

ISSN :
15323064
Volume :
202
Database :
OpenAIRE
Journal :
Respiratory medicine
Accession number :
edsair.doi.dedup.....13e3a114a3a73aaa215888888c941c14